Novel Coronavirus (SARS-CoV-2/COVID-19)
The Occupational Safety and Health Administration today reopened the comment period for certain topics in its interim final rule establishing an emergency temporary standard for occupational exposure to COVID-19.
At the height of the pandemic and patient surges, New York-based Northwell Health and Utah-based Intermountain Healthcare began collaborating on how to address each system’s staffing shortfalls. Intermountain would soon deploy 48 team members to Northwell, which later returned the favor.
The Food and Drug Administration last week authorized for emergency use a new over-the-counter COVID-19 test.
Mask mandates are being lifted in cities and towns across the U.S. and more employees are transitioning from remote work at home and returning to their offices, so people are wondering: Are we nearing the end of the pandemic?
Studies show benefits of mRNA vaccines, boosters.
Discover how AHA quickly reframed its strategic plan to help hospitals navigate through COVID-19 challenges. Join AHA CEO Rick Pollack in this video conversation to learn more.
As of January, only 27 states had a plan for how they will prioritize Medicaid eligibility and renewal actions when the continuous enrollment requirement ends after the COVID-19 public health emergency, according to a survey released by the Kaiser Family Foundation.
The COVID-19 Uninsured Program will stop accepting claims for testing and treatment on March 22 at 11:59 p.m. ET and claims for vaccination on April 5 at 11:59 p.m. ET due to lack of sufficient funds, the Health Resources and Services Administration announced.
Weekly COVID-19-associated hospitalization rates among U.S. infants and children under age 5 have declined since peaking Jan. 8, but peak rates during omicron predominance were about five times those during delta predominance, the Centers for Disease Control and Prevention reported.
Without additional funding from Congress, the U.S. cannot secure sufficient COVID-19 vaccine boosters and variant-specific vaccines for all Americans; reimburse providers to test, treat and vaccinate the uninsured; provide monoclonal antibody therapies to states; or sustain testing capacity, among…